Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Twist Bioscience Corporation - Common Stock (NQ:TWST)

188.05 -5.19 (-2.69%)
Delayed Quote Updated: 4:00 PM EDT, Oct 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,117,105
Open 193.10
Bid (Size) 187.25 (200)
Ask (Size) 188.93 (200)
Prev. Close 193.24
Today's Range 187.60 - 200.31
52wk Range 23.30 - 200.31
Shares Outstanding 50,885,068
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Why Twist Bioscience Stock Skyrocketed This Week ↗
It's plugging into a state-of-the-art research tool developed by a major pharmaceutical company. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Twist Bioscience Joins Lilly TuneLab to Advance Antibody Drug Discovery
From Twist Bioscience Corporation
Via Business Wire

Performance

YTD
+480.6%
+480.6%
1 Month
+35.3%
+35.3%
3 Month
+83.9%
+83.9%
6 Month
+279.6%
+279.6%
1 Year
+568.3%
+568.3%

More News

Read More
News headline image
Twist Bioscience to Present at Baird 2026 Global Healthcare Conference
From Twist Bioscience Corporation
Via Business Wire
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
Twist Bioscience TWST Q2 Fiscal 2026: Revenue Beat Offset by Wider EPS Miss ↗
Via Chartmill
News headline image
Twist Bioscience (TWST) Q3 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Twist Bioscience Announces Pricing of Upsized $300.0 Million Public Offering of Common Stock
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Announces Proposed Public Offering of $250.0 Million of Common Stock
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Sees AI Drug Discovery Pipeline Expand ↗
Via Benzinga
Topics Artificial Intelligence
News headline image
Twist Bioscience Q3 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
Twist Bioscience Announces Fiscal 2026 Third Quarter Financial Results
From Twist Bioscience Corporation
Via Business Wire
News headline image
Cathie Wood Is Selling This High-Flying Stock. Is It a Buy? ↗
Via The Motley Fool
Topics ETFs
News headline image
Twist Bioscience to Report Fiscal 2026 Third Quarter Financial Results on Monday, August 3, 2026
From Twist Bioscience Corporation
Via Business Wire
News headline image
The Next Wave of Medical AI Could Mint More Millionaires Than the First -- Here Are the Stocks to Own ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Twist Bioscience Director Sold 12,000 Shares. Here's What That Means for Investors. ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Twist Bioscience's Chief Legal Officer Sold Over 14,000 Company Shares. What Does That Mean for Investors? ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Twist Biosciences' (TWST) CEO Sold 16,000 Shares for $1.1 Million ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Twist Bioscience to Present at William Blair 46th Annual Growth Stock Conference
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist (TWST) Q2 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Artificial Intelligence Earnings
News headline image
Twist (TWST) Q3 2025 Earnings Transcript ↗
Via The Motley Fool
News headline image
Twist Bioscience Expands Clonal Genes Offering to Include Long and Complex Sequences
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience Announces Fiscal 2026 Second Quarter Financial Results
From Twist Bioscience Corporation
Via Business Wire
News headline image
Twist Bioscience to Report Fiscal 2026 Second Quarter Financial Results on Monday, May 4, 2026
From Twist Bioscience Corporation
Via Business Wire

Frequently Asked Questions

Is Twist Bioscience Corporation - Common Stock publicly traded?
Yes, Twist Bioscience Corporation - Common Stock is publicly traded.
What exchange does Twist Bioscience Corporation - Common Stock trade on?
Twist Bioscience Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Twist Bioscience Corporation - Common Stock?
The ticker symbol for Twist Bioscience Corporation - Common Stock is TWST on the Nasdaq Stock Market
What is the current price of Twist Bioscience Corporation - Common Stock?
The current price of Twist Bioscience Corporation - Common Stock is 188.05
When was Twist Bioscience Corporation - Common Stock last traded?
The last trade of Twist Bioscience Corporation - Common Stock was at 10/01/26 04:00 PM ET
What is the market capitalization of Twist Bioscience Corporation - Common Stock?
The market capitalization of Twist Bioscience Corporation - Common Stock is 9.57B
How many shares of Twist Bioscience Corporation - Common Stock are outstanding?
Twist Bioscience Corporation - Common Stock has 10B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.